http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
DEINOVE & Dow Sign a Collaboration Agreement for the Development of a New Cosmetic Active Ingredient
DEINOVE & Dow sign a collaboration agreement for the development of a new cosmetic active ingredient
-
Deinove will market a 2nd proprietary carotenoid-based cosmetic active ingredient in 2019
-
DEINOVE to collaborate with CALIBR to explore broadly the anti-infectious potentials of its bacterial collection
-
DEINOVE to Collaborate with Calibr to Explore Broadly the Anti-Infectious Potentials of Its Bacterial Collection
-
STRATEGIC PARTNERSHIP BETWEEN DEINOVE AND SOLVAY FOR THE MARKETING OF PHYTOENE IN NORTH AMERICA AND ASIA
-
Strategic Partnership Between DEINOVE and Solvay for the Marketing of Phytoene in North America and Asia
-
DEINOVE is the Regional Winner of the ‘PME Bougeons-Nous’ Awards in the ‘Creative Business’ Category
-
Deinove : 2018 half-year consolidated results
-
Deinove : Strategic partnership with UNIVAR for the distribution of Phyt-N-Resist® in the EMEA zone
-
Strategic Partnership between DEINOVE and UNIVAR for the Distribution of Phyt-N-Resist® in the EMEA Zone
-
Deinove enters into collaboration with bioMérieux to discover new antibiotics
-
DEINOVE Enters into Collaboration with Biomérieux to Discover New Antibiotics
-
Deinove : Arrowhead initiates coverage on Deinove in the United States
-
DEINOVE and OLEOS expand their collaboration with the support of the Occitanie Region
-
DEINOVE : COLOR2B Project: Confirmed Progress and Outlook
-
Deinove : COLOR2B project: confirmed progress and outlook
-
DEINOVE and GREENTECH launch HEBELYS, their 1st cosmetic ingredient
-
DEINOVE TAKES ON A WHOLE NEW DIMENSION WITH THE ACQUISITION OF MORPHOCHEM'S CLINICAL-STAGE ANTIBIOTIC COMPOUND
-
DEINOVE Takes on a Whole New Dimension with the Acquisition of MORPHOCHEM’s Clinical-Stage Antibiotic Compound
-
Deinove introduces Phyt-N-Resist, the first pure phytoene for skincare
-
Deinove Introduces Phyt-N-Resist®, the First Pure Phytoene for Skincare
-
Deinove : 2017: financial results in line with the development strategy
-
DEINOVE expands its innovative antibiotic portfolio by signing a license option agreement with REDX PHARMA
-
DEINOVE COLLABORATES WITH NAICONS TO DISCOVER NEW ANTIBIOTICS IN THE FRAME OF THE AGIR PROJECT
-
Deinove announces the success of its cosmetic active ingredient's production process industrialization
-
DEINOVE and Oléos, partners in the development of a new cosmetic active ingredient
-
HALF-YEAR CONSOLIDATED RESULTS: STABILITY OF NET LOSS & MAJOR PROGRESS ON R&D PROGRAMS
-
The AGIR Project Carried out by the DEINOVE Group is Granted €14.6 Million by the ‘Investments for the Future’ Program (IFP) Operated by Bpifrance to Develop New Antibiotics
-
Deinove : The AGIR project carried out by the DEINOVE group is granted €14.6 m
-
DEINOVE strengthens its Business Development activity with the arrival of Sébastien Enault
-
DEINOVE WELCOMES ITS NEW DIRECTOR OF R&D, GEORGES GAUDRIAULT, PhD
-
Deinove : Shareholders' meeting of May 16, 2017: Hervé BRAILLY joins the Board of Directors
-
DEINOVE's first patent in animal nutrition
-
COLOR2B Project: The potential of Deinove's strains validated by Avril
-
COLOR2B Project: The Potential of DEINOVE’s Strains Validated by AVRIL
-
2016 ANNUAL RESULTS: STRATEGIC FOCUS ON TRACK - PROMISING RESULTS IN THE FIELDS OF HEALTH, NUTRITION & COSMETICS
-
DEINOVE reaches the third milestone of the DEINOL program and receives EU 1.2 m from Bpifrance
-
DEINOVE reaches the third milestone of the DEINOL program and receives EU 1.2 m from Bpifrance

